HS

Hemant Sachdeva

Active Director Director DIN 08937731
DIN 08937731 First appointment Jan 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Hemant Sachdeva

Data last updated:

Hemant Sachdeva is a Director at Tirupati Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Tirupati Pharmaceuticals Private Limited reported revenue of ₹73.1 Lakh (FY 2021).

DIN 08937731
Primary Designation Director
Industry Healthcare
First Appointment 01 Jan 2021
Oldest Company Age 17 yrs
Largest company Tirupati Pharmaceuticals Private Limited · ₹73.1 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 20212009₹73.1 Lakh (FY 2021)Active

Board colleagues of Hemant Sachdeva

Directorship timeline

Open interactive timeline →
Tirupati Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hemant Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemant Sachdeva

Hemant Sachdeva currently holds 1 directorship: Tirupati Pharmaceuticals Private Limited (Director, since 01 Jan 2021, revenue ₹73.1 Lakh (FY 2021)).

Hemant Sachdeva was first appointed on 01 Jan 2021 as Director at Tirupati Pharmaceuticals Private Limited.

The current boards of Hemant Sachdeva's companies include Anubhav Malik (Tirupati Pharmaceuticals Private Limited), Jyoti Malik (Tirupati Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available